How does thyroid affect the heart in health and disease?

Triiodothyronine (T3) exerts a profound, dual-pronged effect on the cardiovascular system: it acts directly on the cardiomyocyte to alter gene expression and ion channel activity, and indirectly on the peripheral vasculature to shift systemic hemodynamics.

Here is a breakdown of the physiological mechanisms and how they manifest in clinical disease states.

Physiologic Mechanisms in Health

The cardiovascular system is one of the most sensitive targets of thyroid hormone. T4 is converted to the biologically active T3 via deiodinases in peripheral tissues and within the myocardium itself.

1. Direct Cellular Effects

• Genomic Actions: T3 enters the myocyte nucleus and binds to thyroid hormone receptors (TRs). This upregulates the expression of the sarcoplasmic reticulum Ca²⁺-ATPase (SERCA2a) and α-myosin heavy chain (α-MHC), while downregulating phospholamban and β-MHC. The net result is enhanced myocardial contractility (inotropy) and faster diastolic relaxation (lusitropy).
• Non-Genomic Actions: T3 rapidly alters plasma membrane ion channels, independent of transcription. It increases the activity of the Na⁺/K⁺-ATPase and various voltage-gated potassium channels, accelerating depolarization and repolarization, which directly increases resting heart rate (chronotropy).

2. Systemic Hemodynamic Effects

T3 has a direct relaxing effect on vascular smooth muscle cells, leading to peripheral vasodilation and a significant drop in systemic vascular resistance (SVR).

This drop in SVR decreases effective arterial filling volume, which triggers a compensatory activation of the Renin-Angiotensin-Aldosterone System (RAAS). The resulting sodium and water retention increases plasma volume and preload. The combination of decreased afterload (low SVR), increased preload, and direct positive inotropy/chronotropy results in a substantial increase in cardiac output.

Thyroid-Heart Axis in Disease

When thyroid function deviates, the finely tuned hemodynamic balance collapses, presenting classic cardiovascular phenotypes.

State	Hemodynamics	Arrhythmia Risk	Structural / Clinical Manifestations
Hyperthyroidism	↑ CO, ↓ SVR, ↑ resting HR	High risk of Atrial Fibrillation (10-15% of patients) due to shortened refractory periods.	High-output heart failure, exacerbation of underlying CAD/angina, systolic hypertension.
Hypothyroidism	↓ CO, ↑ SVR, ↓ resting HR	Sinus bradycardia, AV blocks, prolonged QT interval.	Pericardial effusion (usually asymptomatic), diastolic dysfunction, accelerated atherosclerosis (via dyslipidemia).

The “Low T3 Syndrome” in Heart Failure

In states of chronic severe heart failure, peripheral conversion of T4 to T3 is often impaired, leading to a state known as euthyroid sick syndrome (or Low T3 syndrome). This is not merely an adaptive response to stress but is strongly correlated with worsening NYHA class and increased cardiovascular mortality. The local myocardial deficiency of T3 exacerbates pathologic remodeling, further downregulating SERCA2a and contributing to a downward spiral of declining contractile function.